Immunotherapy advances in triple-negative breast cancer drive personalized treatments with immune checkpoint inhibitors, aiding subtype identification and new combination therapy developments.

BYU students will have an opportunity this month to register with the National Marrow Donor Program, or NMDP, to potentially ...

March has been declared Multiple Myeloma Month in BC following the efforts of an advocacy group in Abbotsford. Multiple ...

LTRN READ THE FULL LTRN RESEARCH REPORT Lantern Pharma, Inc (NASDAQ:LTRN) continues to enroll its HARMONIC trial for LP-300 ...

Researchers from Creatv Bio, Division of Creatv MicroTech, Inc. (Monmouth Junction, NJ) and The Mayo Clinic (Jacksonville, FL), in collaboration with BriaCell Therapeutics Corporation (Philadelphia, ...

On April 6, 2025, runners and fitness enthusiasts will gather at Ayala Triangle, Makati for the first-ever “Run to Share,” an event led by the I Want To Share Foundation to raise funds to ...

Boxing champion turned I'm a Celebrity star Barry McGuigan has come to the aid of a Telford woman who is trying to raise £120 ...

Q4 2024 Earnings Call Transcript March 13, 2025 Seres Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.1, ...

More than 200 products from 28 makeup, sunscreen, and shaving cream brands contained Teflon and other forever chemicals, ...

Targeted chemotherapy in the abdomen using a technique called PIPAC combined with systemic standard-of-care chemotherapy is shown to be safe, with promising activity for patients with colorectal and a ...

Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support for the proposed ...

DSU’s unwavering dedication to social impact is a testament to its holistic educational approach, seamlessly integrating ...